We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$947M
AUM Growth
+$67.9M
Cap. Flow
-$19M
Cap. Flow %
-2.01%
Top 10 Hldgs %
31.65%
Holding
277
New
24
Increased
72
Reduced
85
Closed
14

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$16.1M
2
EXC icon
Exelon
EXC
+$6.81M
3
CROX icon
Crocs
CROX
+$5.78M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.63M
5
AVY icon
Avery Dennison
AVY
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Industrials 17.97%
3 Healthcare 12.8%
4 Consumer Discretionary 12.43%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFB
276
DELISTED
MAIDENFORM BRANDS, INC
MFB
-191,300
Closed -$4.49M
CB
277
DELISTED
CHUBB CORPORATION
CB
-4,486
Closed -$400K

Similar funds

Shufro Rose & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Shufro Rose & Co held 277 positions worth $947M, up 7.7% from $879M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Shufro Rose & Co's Q4 2013 filing shows 24 new, 72 increased, 85 reduced and 14 closed positions. Its largest new stake was Rockwell Collins: 145,705 shares worth $10.8M. The largest sale was Teva Pharmaceuticals, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q4 2013 buy was Rockwell Collins: 145,705 shares worth $10.8M.
  • Shufro Rose & Co added most to Vishay Precision Group in Q4 2013, an estimated $1.63M increase.
  • Shufro Rose & Co's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $16.1M.
  • Shufro Rose & Co fully exited MAIDENFORM BRANDS, INC in Q4 2013, selling an estimated $4.49M.
  • Shufro Rose & Co's ten largest holdings make up 32% of its $947M portfolio in Q4 2013.
  • Shufro Rose & Co opened 24 new positions and closed 14 in Q4 2013.
  • Shufro Rose & Co's portfolio value rose 7.7% quarter-over-quarter to $947M.

Based on Shufro Rose & Co's 13F filing for Q4 2013, filed 4 Feb 2014.